-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $127

Benzinga·05/06/2026 14:32:22
Listen to the news
Citizens analyst Daniel Stauder maintains LeMaitre Vascular (NASDAQ:LMAT) with a Market Outperform and raises the price target from $118 to $127.